🔴 Neurosense Therapeutics is trading 5.6% down amid a biotech-sector selloff

Neurosense Therapeutics is trading at $1.34, down 5.63% during the November 5, 2026 session, amid a broader biotech-sector selloff.

• The provided sector context reports XBI down 5.19%, while major market indexes are also sharply lower.
• No fresh company-specific announcement explaining the decline surfaced in the search.
• The H.C. Wainwright downgrade and news about delayed PrimeC timelines were reported November 2, not November 5, so they are not clear same-day catalysts.